Description
*Read carefully the package insert before use.
Performance Data
Within-run reproducibility
[sec]
Sample 1 | Sample 2 | |
---|---|---|
1 | 31.3 | 59.2 |
2 | 31.8 | 60.3 |
3 | 31.7 | 61.0 |
4 | 32.0 | 60.8 |
5 | 31.3 | 60.8 |
6 | 32.1 | 60.3 |
7 | 32.1 | 60.6 |
8 | 31.9 | 60.6 |
9 | 31.5 | 60.5 |
10 | 32.0 | 60.3 |
Mean | 31.8 | 60.4 |
S.D. | 0.31 | 0.50 |
C.V. (%) | 1.00 | 0.83 |
Max. | 32.1 | 61.0 |
Min. | 31.3 | 59.2 |
Range | 0.8 | 1.8 |
On-Board Stability (After Reconstitution)
[on Coapresta 2000]

Interference
Concentration | Measured Value(sec) | ||
---|---|---|---|
Base Plasma | Including Interfering Substance | ||
Unconjugated Bilirubin |
20 mg/dL | 28.0 | 28.5 |
Conjugated Bilirubin |
20 mg/dL | 28.3 | 28.4 |
Hemoglobin | 500 mg/dL | 28.5 | 28.2 |
Chyle | 3000 FTU | 28.3 | 28.4 |
LA Sensitivity (Mixing Study)
Using CP2000’s multipoint dilution function, LA positive samples and coagulation factor deficient plasma were measured at 7 points. LA positive sample produces a concave graph while the coagulation factor deficient sample produces a convex graph.

Heparin Sensitivity

Correlation

Assay Procedure

Coagpia APTT-N